bibliographicCitation |
Giagounidis A, Mufti GJ, Fenaux P, Germing U, List A, MacBeth KJ. Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes. Annals of Hematology. 2013 Sep 10;93(1):1–11. doi: 10.1007/s00277-013-1863-5. |